Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

May 15, 2017 (Vol. 37, No. 10)

Biomarker Validation for Genomic Assays

Assay Developers Put Their Tests to the Test and Demonstrate the Clinical Utility of Genomic Biomarkers

  • Pity the genomic scientist who specializes in biomarker development, a discipline that is still being built around next-generation sequencing (NGS). This new discipline, which could be called next-generation molecular diagnostic assay validation, is currently grappling with a range of challenges: biospecimens that are rare and of uncertain quality, analytes ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.